BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20041408)

  • 1. Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis.
    Pelletier L; Rebouissou S; Paris A; Rathahao-Paris E; Perdu E; Bioulac-Sage P; Imbeaud S; Zucman-Rossi J
    Hepatology; 2010 Feb; 51(2):557-66. PubMed ID: 20041408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation.
    Rebouissou S; Imbeaud S; Balabaud C; Boulanger V; Bertrand-Michel J; Tercé F; Auffray C; Bioulac-Sage P; Zucman-Rossi J
    J Biol Chem; 2007 May; 282(19):14437-46. PubMed ID: 17379603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HNF1α inhibition triggers epithelial-mesenchymal transition in human liver cancer cell lines.
    Pelletier L; Rebouissou S; Vignjevic D; Bioulac-Sage P; Zucman-Rossi J
    BMC Cancer; 2011 Oct; 11():427. PubMed ID: 21975049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CYP1B1 germ line mutations with hepatocyte nuclear factor 1alpha-mutated hepatocellular adenoma.
    Jeannot E; Poussin K; Chiche L; Bacq Y; Sturm N; Scoazec JY; Buffet C; Van Nhieu JT; Bellanné-Chantelot C; de Toma C; Laurent-Puig P; Bioulac-Sage P; Zucman-Rossi J
    Cancer Res; 2007 Mar; 67(6):2611-6. PubMed ID: 17363580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I.
    Calderaro J; Labrune P; Morcrette G; Rebouissou S; Franco D; Prévot S; Quaglia A; Bedossa P; Libbrecht L; Terracciano L; Smit GP; Bioulac-Sage P; Zucman-Rossi J
    J Hepatol; 2013 Feb; 58(2):350-7. PubMed ID: 23046672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
    Ladeiro Y; Couchy G; Balabaud C; Bioulac-Sage P; Pelletier L; Rebouissou S; Zucman-Rossi J
    Hepatology; 2008 Jun; 47(6):1955-63. PubMed ID: 18433021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtype classification of hepatocellular adenoma.
    Bioulac-Sage P; Balabaud C; Zucman-Rossi J
    Dig Surg; 2010; 27(1):39-45. PubMed ID: 20357450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.
    Bioulac-Sage P; Rebouissou S; Thomas C; Blanc JF; Saric J; Sa Cunha A; Rullier A; Cubel G; Couchy G; Imbeaud S; Balabaud C; Zucman-Rossi J
    Hepatology; 2007 Sep; 46(3):740-8. PubMed ID: 17663417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.
    Bioulac-Sage P; Laumonier H; Couchy G; Le Bail B; Sa Cunha A; Rullier A; Laurent C; Blanc JF; Cubel G; Trillaud H; Zucman-Rossi J; Balabaud C; Saric J
    Hepatology; 2009 Aug; 50(2):481-9. PubMed ID: 19585623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected discovery of small HNF1α-inactivated hepatocellular adenoma in pathological specimens from patients resected for liver tumours.
    Balabaud C; Laurent C; Le Bail B; Castain C; Possenti L; Frulio N; Chiche L; Blanc JF; Bioulac-Sage P
    Liver Int; 2018 Jul; 38(7):1273-1279. PubMed ID: 29265678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease.
    Kishnani PS; Chuang TP; Bali D; Koeberl D; Austin S; Weinstein DA; Murphy E; Chen YT; Boyette K; Liu CH; Chen YT; Li LH
    Hum Mol Genet; 2009 Dec; 18(24):4781-90. PubMed ID: 19762333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.
    Zucman-Rossi J; Jeannot E; Nhieu JT; Scoazec JY; Guettier C; Rebouissou S; Bacq Y; Leteurtre E; Paradis V; Michalak S; Wendum D; Chiche L; Fabre M; Mellottee L; Laurent C; Partensky C; Castaing D; Zafrani ES; Laurent-Puig P; Balabaud C; Bioulac-Sage P
    Hepatology; 2006 Mar; 43(3):515-24. PubMed ID: 16496320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
    Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
    Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New monoallelic (partial tandem duplication) mutation of HNF1a gene in steatotic hepatocellular adenoma.
    Sakellariou S; Morgan Y; Heaton N; Portmann B; Quaglia A; Tobal K
    Eur J Gastroenterol Hepatol; 2011 Jul; 23(7):623-7. PubMed ID: 21566527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary hepatocellular neoplasms in a MODY3 family with a novel HNF1A germline mutation.
    Willson JS; Godwin TD; Wiggins GA; Guilford PJ; McCall JL
    J Hepatol; 2013 Oct; 59(4):904-7. PubMed ID: 23707370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of TCF1 encoding hepatocyte nuclear factor 1alpha in gynecological cancer.
    Rebouissou S; Rosty C; Lecuru F; Boisselier S; Bui H; Le Frere-Belfa MA; Sastre X; Laurent-Puig P; Zucman-Rossi J
    Oncogene; 2004 Sep; 23(45):7588-92. PubMed ID: 15326484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas.
    Rebouissou S; Vasiliu V; Thomas C; Bellanné-Chantelot C; Bui H; Chrétien Y; Timsit J; Rosty C; Laurent-Puig P; Chauveau D; Zucman-Rossi J
    Hum Mol Genet; 2005 Mar; 14(5):603-14. PubMed ID: 15649945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular Adenomas: Morphology and Genomics.
    Bioulac-Sage P; Sempoux C; Balabaud C
    Gastroenterol Clin North Am; 2017 Jun; 46(2):253-272. PubMed ID: 28506364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of inflammatory hepatocellular adenomas with HNF1α-inactivated adenomas: is there an association?
    Castain C; Sempoux C; Brunt EM; Causse O; Heitzmann A; Hernandez-Prera JC; Le Bail B; Schirmacher P; Thung SN; Balabaud C; Bioulac-Sage P
    Histopathology; 2014 May; 64(6):890-5. PubMed ID: 24236804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage.
    Jeannot E; Mellottee L; Bioulac-Sage P; Balabaud C; Scoazec JY; Tran Van Nhieu J; Bacq Y; Michalak S; Buob D; ; Laurent-Puig P; Rusyn I; Zucman-Rossi J
    Diabetes; 2010 Jul; 59(7):1836-44. PubMed ID: 20393147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.